Manhattan Scientifics, Inc.
MHTX · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $671 | $1,734 | $1,454 | $2,517 |
| - Cash | $38 | $51 | $67 | $89 |
| + Debt | $60 | $60 | $60 | $60 |
| Enterprise Value | $693 | $1,743 | $1,447 | $2,488 |
| Revenue | $0 | $0 | $2 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $1 | $0 |
| % Margin | – | – | 50% | – |
| EBITDA | -$160 | -$192 | -$254 | -$180 |
| % Margin | – | – | -12,700% | – |
| Net Income | -$158 | -$382 | -$254 | -$262 |
| % Margin | – | – | -12,700% | – |
| EPS Diluted | -0 | -0.001 | -0.001 | -0.001 |
| % Growth | 57.1% | -40% | 0% | – |
| Operating Cash Flow | -$17 | -$42 | -$14 | -$37 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$17 | -$42 | -$14 | -$37 |